These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31322413)

  • 21. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
    Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
    Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovative Therapeutic Strategies in the Treatment of Meningioma.
    Caruso G; Elbabaa SK; Gonzalez-Lopez P; Barresi V; Passalacqua M; Caffo M
    Anticancer Res; 2015 Dec; 35(12):6391-400. PubMed ID: 26637848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
    Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
    Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.
    Gupta V; Samuleson CG; Su S; Chen TC
    Neurosurg Focus; 2007; 23(4):E9. PubMed ID: 17961046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of radiotherapy in the management of high-grade meningiomas.
    Hwang KL; Hwang WL; Bussière MR; Shih HA
    Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S5. PubMed ID: 28758409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
    Palma L; Celli P; Franco C; Cervoni L; Cantore G
    J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal treatment of parasagittal meningiomas: a single-center experience.
    Gatterbauer B; Gevsek S; Höftberger R; Lütgendorf-Caucig C; Ertl A; Mallouhi A; Kitz K; Knosp E; Frischer JM
    J Neurosurg; 2017 Dec; 127(6):1249-1256. PubMed ID: 28156245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current treatment options for meningioma.
    Apra C; Peyre M; Kalamarides M
    Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.
    Gupta V; Su YS; Samuelson CG; Liebes LF; Chamberlain MC; Hofman FM; Schönthal AH; Chen TC
    J Neurosurg; 2007 Mar; 106(3):455-62. PubMed ID: 17367069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
    Pearson BE; Markert JM; Fisher WS; Guthrie BL; Fiveash JB; Palmer CA; Riley K
    Neurosurg Focus; 2008; 24(5):E3. PubMed ID: 18447742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up.
    Newton HB; Scott SR; Volpi C
    Br J Neurosurg; 2004 Oct; 18(5):495-9. PubMed ID: 15799152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
    Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
    World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case report.
    Raheja A; Colman H; Palmer CA; Couldwell WT
    J Neurosurg; 2017 Nov; 127(5):965-970. PubMed ID: 27935362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.
    Maier H; Ofner D; Hittmair A; Kitz K; Budka H
    J Neurosurg; 1992 Oct; 77(4):616-23. PubMed ID: 1527622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trabectedin has promising antineoplastic activity in high-grade meningioma.
    Preusser M; Spiegl-Kreinecker S; Lötsch D; Wöhrer A; Schmook M; Dieckmann K; Saringer W; Marosi C; Berger W
    Cancer; 2012 Oct; 118(20):5038-49. PubMed ID: 22392434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review.
    Graillon T; Romano D; Defilles C; Saveanu A; Mohamed A; Figarella-Branger D; Roche PH; Fuentes S; Chinot O; Dufour H; Barlier A
    J Neurosurg; 2017 Sep; 127(3):660-669. PubMed ID: 27982767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
    Chamberlain MC; Glantz MJ; Fadul CE
    Neurology; 2007 Sep; 69(10):969-73. PubMed ID: 17785665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution.
    Pisćević I; Villa A; Milićević M; Ilić R; Nikitović M; Cavallo LM; Grujičić D
    World Neurosurg; 2015 Jun; 83(6):987-95. PubMed ID: 25769488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
    Chamberlain MC
    Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.